Brief: Abivax Announces Abtect Phase 3 Trial Achieves Key Enrollment Milestone

Abivax SA

06/08/2024 07:32

Aug 6 (Reuters) - Abivax SA  ABVX.PA :
    * ABIVAX ANNOUNCES ABTECT PHASE 3 TRIAL ACHIEVES KEY
ENROLLMENT
MILESTONE
    * TO DATE, BASELINE PARTICIPANTS BASELINE CHARACTERISTICS
AND
TRIAL TRENDS IN LINE WITH OBSERVATIONS FROM PHASE 2B TRIAL
    * COMPANY REAFFIRMS EXPECTATIONS TO REACH FULL ENROLLMENT IN
EARLY
Q1 2025

Source text for Eikon:  ID:nGNX7mf9yw 
Further company coverage:  ABVX.PA 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))